Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in J Cardiol Retrieve available abstracts of 103 articles: HTML format

Single Articles

June 2024
1. OKISHIGE K, Tachibana S, Shigeta T, Yamauchi Y, et al
   Novel method to avoid serious injurious effects on the atrioventricular nodal (AVN) conduction during catheter ablation of the AVN slow pathway utilizing cryofreezing energy.
   J Cardiol. 2024;83:371-376.
   PubMed     Abstract available
   
   
   May 2024
2. YAMAGUCHI T
   Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
   J Cardiol. 2024 May 27:S0914-5087(24)00096-0. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
3. KURODA S, Kawamura I, Sahashi Y, Kuno T, et al
   The significance of non-sustained ventricular tachycardia on life-threatening ventricular arrhythmia events in patients with non-ischemic cardiomyopathy in the contemporary era: A systematic review and meta-analysis.
   J Cardiol. 2024 May 14:S0914-5087(24)00086-8. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
4. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
   Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
   J Cardiol. 2024;83:313-317.
   PubMed     Abstract available
   
   
   March 2024
5. BAZOUKIS G, Saplaouras A, Efthymiou P, Yiannikourides A, et al
   Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
   J Cardiol. 2024 Mar 31:S0914-5087(24)00053-4. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   
6. IMBURGIO S, Johal A, Akhlaq H, Klei L, et al
   Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.
   J Cardiol. 2024 Mar 27:S0914-5087(24)00054-6. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   February 2024
7. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
   Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
   J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
   PubMed     Abstract available
   
   
   December 2023
8. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
   Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
   J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
   PubMed     Abstract available
   
   
   November 2023
9. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
   Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
   J Cardiol. 2023;82:363-370.
   PubMed     Abstract available
   
   
   
10. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    PubMed     Abstract available
    
    
    October 2023
11. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
12. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
13. NAKATSUKASA T, Ishizu T, Minami K, Kawamatsu N, et al
    Reverse remodeling of the tricuspid valve complex by sinus rhythm restoration after catheter ablation.
    J Cardiol. 2023;82:248-256.
    PubMed     Abstract available
    
    
    September 2023
14. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    August 2023
15. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
    J Cardiol. 2023 Aug 12:S0914-5087(23)00191-0. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
16. KHALID SI, Sathianathan S, Thomson KB, McGuire LS, et al
    5-year Stroke Rates in Nonvalvular Atrial Fibrillation after Watchman compared to Direct Oral Anticoagulants.
    J Cardiol. 2023 Aug 2:S0914-5087(23)00181-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
17. IMAMURA S, Miyata M, Tagata K, Yokomine T, et al
    Prognostic predictors in patients with cardiopulmonary arrest: A novel equation for evaluating the 30-day mortality.
    J Cardiol. 2023;82:146-152.
    PubMed     Abstract available
    
    
    July 2023
18. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Left atrial appendage peak flow velocity predicts improvement in mitral regurgitation after atrial fibrillation ablation.
    J Cardiol. 2023 Jul 19:S0914-5087(23)00165-X. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
19. OKAMOTO H, Miyake M, Hayashi A, Matsutani H, et al
    Differences in clinical and echocardiographic features and outcomes between atrial functional mitral regurgitation patients with and without posterior mitral leaflet bending.
    J Cardiol. 2023;82:22-28.
    PubMed     Abstract available
    
    
    
20. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    PubMed     Abstract available
    
    
    June 2023
21. KAWAKAMI H, Saito M, Fujisawa T, Nagai T, et al
    A cost-effectiveness analysis of remote monitoring after pacemaker implantation for bradycardia in Japan.
    J Cardiol. 2023 Jun 19:S0914-5087(23)00139-9. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
22. KITAHARA H, Yamashita D, Sato T, Suzuki S, et al
    Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2023 Jun 17:S0914-5087(23)00138-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    May 2023
23. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    PubMed    
    
    
    
24. HAMEED I, Malik S, Nusrat K, Siddiqui OM, et al
    Effect of vitamin D on postoperative atrial fibrillation in patients who underwent coronary artery bypass grafting: A systematic review and Meta-analysis.
    J Cardiol. 2023 May 24:S0914-5087(23)00113-2. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
25. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    PubMed     Abstract available
    
    
    April 2023
26. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    March 2023
27. CHOW JK, Bagai A, Tan MK, Har BJ, et al
    Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
    J Cardiol. 2023 Mar 15:S0914-5087(23)00052-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
28. BUKHARI S, Khan B
    Prevalence of Ventricular Arrhythmias and Role of Implantable Cardioverter-Defibrillator in Cardiac Amyloidosis.
    J Cardiol. 2023 Mar 7:S0914-5087(23)00048-5. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
29. TERASAKA N, Spanopoulos D, Miyagoshi H, Kubo T, et al
    Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
    J Cardiol. 2023;81:316-322.
    PubMed     Abstract available
    
    
    February 2023
30. MIYAZAKI Y, Yamagata K, Wakamiya A, Shimamoto K, et al
    Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00044-8. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
31. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00043-6. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
32. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
33. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    PubMed     Abstract available
    
    
    
34. KATAOKA N, Imamura T, Uchida K, Koi T, et al
    Urgent catheter ablation in Japanese patients with mechanical circulatory supports suffering from refractory ventricular electrical storm.
    J Cardiol. 2023;81:229-235.
    PubMed     Abstract available
    
    
    January 2023
35. WADA H, Miyauchi K, Suwa S, Miyazaki S, et al
    Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.
    J Cardiol. 2023 Jan 12:S0914-5087(22)00331-8. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
36. NAKAHARA S
    Catheter ablation of ventricular tachycardia associated with structural heart disease: Current status and perspectives.
    J Cardiol. 2023;81:57-62.
    PubMed     Abstract available
    
    
    December 2022
37. GASSANOV N, Mutallimov M, Caglayan E, Erdmann E, et al
    ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    J Cardiol. 2022;80:573-577.
    PubMed     Abstract available
    
    
    November 2022
38. IKEDA T, Yamashita T, Akao M, Atarashi H, et al
    Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    J Cardiol. 2022 Nov 22:S0914-5087(22)00282-9. doi: 10.1016/j.jjcc.2022.
    PubMed     Abstract available
    
    
    
39. UENO H, Imamura T, Tanaka S, Fukuda N, et al
    Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: A current overview.
    J Cardiol. 2022 Nov 15. pii: S0914-5087(22)00277.
    PubMed     Abstract available
    
    
    
40. CHEN WT, Li CH, Chou YH, Lin WL, et al
    Post-ablation augmentation of skin sympathetic nerve activity predicts a poor outcome of idiopathic ventricular arrhythmias.
    J Cardiol. 2022 Nov 10. pii: S0914-5087(22)00274.
    PubMed     Abstract available
    
    
    October 2022
41. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    PubMed     Abstract available
    
    
    
42. DING L, Weng S, Zhang H, Yu F, et al
    Novel tissue-pressure sensing technology using a wide-band dielectric imaging system: An in vivo study.
    J Cardiol. 2022;80:319-324.
    PubMed     Abstract available
    
    
    
43. NIEHUES P, Wegner FK, Wolfes J, Willy K, et al
    Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS.
    J Cardiol. 2022;80:298-302.
    PubMed     Abstract available
    
    
    September 2022
44. PATSIOU V, Samaras A, Kartas A, Moysidis DV, et al
    Prognostic implications of adherence to OACs among patients with atrial fibrillation: Insights from MISOAC-AF trial.
    J Cardiol. 2022 Sep 27. pii: S0914-5087(22)00241.
    PubMed     Abstract available
    
    
    
45. HATORI Y, Sakai H, Hatori N, Kunishima T, et al
    Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
    J Cardiol. 2022 Sep 12. pii: S0914-5087(22)00220.
    PubMed     Abstract available
    
    
    August 2022
46. MATSUDA S, Kato T, Morimoto T, Taniguchi T, et al
    Atrial fibrillation in patients with severe aortic stenosis.
    J Cardiol. 2022 Aug 23. pii: S0914-5087(22)00206.
    PubMed     Abstract available
    
    
    
47. AKAO M, Tsuji H, Kusano K, Matsui K, et al
    Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
    J Cardiol. 2022 Aug 16. pii: S0914-5087(22)00200.
    PubMed     Abstract available
    
    
    
48. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    PubMed     Abstract available
    
    
    July 2022
49. YAMAZAKI K, Ishida Y, Sasaki S, Toyama Y, et al
    Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    J Cardiol. 2022 Jul 25. pii: S0914-5087(22)00160.
    PubMed     Abstract available
    
    
    June 2022
50. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306].
    J Cardiol. 2022 Jun 29. pii: S0914-5087(22)00154.
    PubMed    
    
    
    
51. HEMMI H, Kataoka N, Imamura T
    Paroxysmal atrial fibrillation as a cause of unexplained syncope.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00139.
    PubMed    
    
    
    
52. YAMASHITA T, Uchiyama S, Atarashi H, Okumura K, et al
    Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.
    J Cardiol. 2022 Jun 15. pii: S0914-5087(22)00096.
    PubMed     Abstract available
    
    
    
53. FUKUNAGA M, Isotani A, Shirai S, Murakami N, et al
    Initial practice of left atrial appendage closure device in Japan; single-center experience.
    J Cardiol. 2022;79:752-758.
    PubMed     Abstract available
    
    
    April 2022
54. VARNEY JA, Dong VS, Tsao T, Sabir MS, et al
    COVID-19 and arrhythmia: An overview.
    J Cardiol. 2022;79:468-475.
    PubMed     Abstract available
    
    
    
55. KUNO T, Takahashi M, So M, Egorova NN, et al
    The association of anticoagulation before admission and survival of patients with COVID-19.
    J Cardiol. 2022;79:489-493.
    PubMed     Abstract available
    
    
    March 2022
56. MIYAZAKI S, Miyauchi K, Hayashi H, Yamashiro K, et al
    Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    J Cardiol. 2022 Mar 25. pii: S0914-5087(22)00058.
    PubMed     Abstract available
    
    
    
57. CHEN WT, Lo LW, Tsai WC, Lin YJ, et al
    Application of dynamic display technology to identify gaps after pulmonary vein isolation in catheter ablation of atrial fibrillation.
    J Cardiol. 2022 Mar 23. pii: S0914-5087(22)00052.
    PubMed     Abstract available
    
    
    
58. MIYAZAKI Y, Yamagata K, Ishibashi K, Inoue Y, et al
    Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
    J Cardiol. 2022 Mar 12. pii: S0914-5087(22)00049.
    PubMed     Abstract available
    
    
    
59. OGURA S, Nakamura K, Morita H, Nakagawa K, et al
    Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    J Cardiol. 2022;79:446-452.
    PubMed     Abstract available
    
    
    February 2022
60. YAMANE T
    Catheter ablation of atrial fibrillation: Current status and near future.
    J Cardiol. 2022 Feb 24. pii: S0914-5087(22)00025.
    PubMed     Abstract available
    
    
    
61. MORI H, Fukui K, Maeda A, Akashi Y, et al
    Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00029.
    PubMed     Abstract available
    
    
    
62. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    PubMed     Abstract available
    
    
    
63. OUCHI K, Sakuma T, Higuchi T, Yoshida J, et al
    Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
    J Cardiol. 2022;79:211-218.
    PubMed     Abstract available
    
    
    
64. NAKAJIMA Y
    Effectiveness and safety of transcatheter left atrial appendage closure.
    J Cardiol. 2022;79:186-193.
    PubMed     Abstract available
    
    
    January 2022
65. CHEN JY, Chen TW, Lu WD
    The HAT2CH2 score predicts neurologic events in patients with cardiac implantable electronic devices without atrial fibrillation.
    J Cardiol. 2022 Jan 8. pii: S0914-5087(21)00385.
    PubMed     Abstract available
    
    
    
66. MIYAZAKI A, Uemura H
    Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch.
    J Cardiol. 2022;79:30-35.
    PubMed     Abstract available
    
    
    December 2021
67. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    PubMed     Abstract available
    
    
    
68. KURAOKA A, Ishizu T, Sato M, Igarashi M, et al
    Left atrial regional strain assessed by novel dedicated three-dimensional speckle tracking echocardiography.
    J Cardiol. 2021;78:517-523.
    PubMed     Abstract available
    
    
    November 2021
69. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    PubMed     Abstract available
    
    
    
70. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    PubMed     Abstract available
    
    
    
71. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    PubMed     Abstract available
    
    
    
72. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    PubMed     Abstract available
    
    
    October 2021
73. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    PubMed     Abstract available
    
    
    
74. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    PubMed     Abstract available
    
    
    
75. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    PubMed     Abstract available
    
    
    
76. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    PubMed     Abstract available
    
    
    
77. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    PubMed     Abstract available
    
    
    
78. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    PubMed    
    
    
    September 2021
79. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    PubMed     Abstract available
    
    
    
80. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    PubMed     Abstract available
    
    
    August 2021
81. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    PubMed     Abstract available
    
    
    
82. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    PubMed     Abstract available
    
    
    July 2021
83. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    PubMed     Abstract available
    
    
    
84. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.
    PubMed    
    
    
    
85. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    PubMed     Abstract available
    
    
    June 2021
86. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    PubMed     Abstract available
    
    
    
87. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    PubMed     Abstract available
    
    
    
88. IMAMURA T
    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.
    PubMed    
    
    
    
89. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    PubMed     Abstract available
    
    
    
90. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    PubMed     Abstract available
    
    
    
91. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed     Abstract available
    
    
    
92. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    PubMed     Abstract available
    
    
    May 2021
93. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    PubMed     Abstract available
    
    
    April 2021
94. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    PubMed     Abstract available
    
    
    
95. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    PubMed     Abstract available
    
    
    
96. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    PubMed     Abstract available
    
    
    
97. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    PubMed     Abstract available
    
    
    March 2021
98. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    PubMed     Abstract available
    
    
    February 2021
99. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    PubMed     Abstract available
    
    
    
100. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
     Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
     J Cardiol. 2021;77:195-200.
     PubMed     Abstract available
     
     
     
101. CHEN JY, Lu WD
     Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
     J Cardiol. 2021;77:166-173.
     PubMed     Abstract available
     
     
     August 2020
102. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
     Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
     J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
     PubMed     Abstract available
     
     
     May 2020
103. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
     The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
     J Cardiol. 2020;75:567-570.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.